Trehalose 30 % Stock Solution
30 % (w/v) trehalose stock - alternative stabiliser for lyophilised and subcutaneous formulations. · GMP catalogue product · CT-00231
Trehalose 30 % Stock Solution is a defined trehalose concentrate for downstream processing. It is an alternative cryo-/lyo-protectant and stabiliser to sucrose for UF/DF and formulation, favoured for lyophilised and subcutaneous products. As a GMP-grade stock it is applied across monoclonal antibodies, vaccines, mRNA and cell & gene therapy.
Why
- Alternative to sucrose - For lyophilised and subcutaneous formulations.
- Concentrated 30 % - Easy to add to the final matrix.
- GMP grade - Catalogue GMP quality, released per lot.
- Multi-application - Formulation stabiliser across platforms.
Specification
| Composition | 30 % (w/v) trehalose |
| Form | Excipient stock concentrate |
| Storage | 15-25 °C (room temperature) |
| Grade | GMP |
Ordering
| Grade | Article No. | Pack size |
|---|---|---|
| GMP | CT-00231 | 100 ml |
View in the shopRequest a quote
Other pack sizes are available on request.
In the downstream process - by application
Trehalose 30 % Stock Solution is used at the following process steps across the four biologics platforms:
Monoclonal antibodies
- UF/DF and formulation - alternative cryo-/lyo-protectant.
Vaccines
- Formulation - stabiliser / cryoprotectant.
mRNA
- LNP formulation - cryoprotectant.
Cell & gene therapy
- Vector formulation - cryoprotection.
Frequently asked questions
What is Trehalose 30 % Stock Solution used for?
It is an alternative stabiliser and cryo-/lyo-protectant to sucrose for formulation.
Is it multi-application?
Yes, it is used across monoclonal antibodies, vaccines, mRNA and cell & gene therapy downstream.
Related: WFI Quality Water (CT-991500) · DPBS w/o Ca & Mg (CT-36500) · GMP-Grade Products